Technical Analysis for GLAXF - GlaxoSmithKline Plc

Grade Last Price % Change Price Change
grade D 20.34 0.00% 0.0000
GLAXF closed unchanged on Monday, July 6, 2020, on 37 percent of normal volume. It ran into resistance at its 50 day moving average.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down
Historical GLAXF trend table...

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
50 DMA Resistance Bearish 0.00%
20 DMA Resistance Bearish 0.00%
50 DMA Resistance Bearish 0.00%
MACD Bearish Centerline Cross Bearish 0.77%
Inside Day Range Contraction 0.77%
Fell Below 20 DMA Bearish 1.24%
Fell Below 50 DMA Bearish 1.24%
MACD Bearish Signal Line Cross Bearish 1.24%
Multiple of Ten Bullish Other 1.24%
Older signals for GLAXF ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

GlaxoSmithKline plc engages in the creation, discovery, development, manufacture, and marketing of vaccines, over-the-counter medicines, and health-related consumer products worldwide. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, anti-virals, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterials, dermatology, rare diseases, immuno-inflammation, and HIV, as well as vaccines. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health categories primarily under the Otrivin, Panadol, Fenistil, Lamisil, Breathe Right, Stiefel, Excedrin, Physiogel, Polident, parodontax, Poligrip, Sensodyne, Theraflu, and Voltaren brand names. The company offers its consumer healthcare products in the form of tablets, caplets, infant syrup drops, syrups, topical gels, nasal sprays, effervescents, lozenges, gum and trans-dermal patches, malted drinks and foods, and topical creams and non-medicated patches, as well as toothpastes, toothbrushes, mouth rinses, medicated mouthwashes, gels and sprays, denture adhesives, and denture cleansers. It has a discovery collaboration agreement with Kymera Therapeutics LLC; a collaboration agreement with InSysBio LLC to develop quantitative systems pharmacology model of asthma; a strategic collaboration with NeuroMetrix, Inc. to develop and market Quell technology; and strategic alliance with Merck KGaA to jointly develop and commercialize M7824 (bintrafusp alfa), an investigational bifunctional fusion protein immunotherapy. GlaxoSmithKline plc also has a joint research collaboration with Fimbrion Therapeutics Inc. to develop a small molecule candidate for the treatment and prevention of urinary tract infections. The company was founded in 1715 and is headquartered in Brentford, the United Kingdom.
Health Pharmaceutical Industry Pharmaceutical Industry In China Pharmaceutical Products Immunotherapy Hiv Asthma Rare Diseases Urinary Tract Infections Consumer Healthcare Products Decongestants Diclofenac

Is GLAXF a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 24.2033
52 Week Low 14.96
Average Volume 5,608
200-Day Moving Average 20.9846
50-Day Moving Average 20.6305
20-Day Moving Average 20.5288
10-Day Moving Average 20.5059
Average True Range 0.6813
ADX 10.75
+DI 21.4271
-DI 23.7306
Chandelier Exit (Long, 3 ATRs ) 19.4561
Chandelier Exit (Short, 3 ATRs ) 21.8939
Upper Bollinger Band 21.2345
Lower Bollinger Band 19.8231
Percent B (%b) 0.37
BandWidth 6.8752
MACD Line -0.0408
MACD Signal Line 0.0011
MACD Histogram -0.0419
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 21.2400
Resistance 3 (R3) 21.2767 21.0133 21.0900
Resistance 2 (R2) 21.0133 20.7841 20.9950 21.0400
Resistance 1 (R1) 20.6767 20.6425 20.8450 20.6400 20.9900
Pivot Point 20.4133 20.4133 20.4975 20.3950 20.4133
Support 1 (S1) 20.0767 20.1841 20.2450 20.0400 19.6900
Support 2 (S2) 19.8133 20.0425 19.7950 19.6400
Support 3 (S3) 19.4767 19.8133 19.5900
Support 4 (S4) 19.4400